Prism Medico & Pharmacy Ltd Hits New 52-Week High at Rs.28.79

Strong Rally and Price Momentum

The stock opened today with a 5.00% gap up at Rs.28.79 and maintained this level throughout the trading session, touching an intraday high of Rs.28.79. This marks the highest price level for Prism Medico & Pharmacy Ltd in the last 52 weeks, surpassing its previous highs and signalling strong buying interest. Over the last nine consecutive trading days, the stock has surged by an impressive 69.85%, underscoring sustained positive momentum.

Trading above all key moving averages — including the 5-day, 20-day, 50-day, 100-day, and 200-day averages — the stock’s technical positioning indicates a solid uptrend. This broad-based strength across multiple timeframes highlights the stock’s resilience and growing investor confidence within the NBFC sector.

Outperformance Against Sector and Benchmark

Prism Medico & Pharmacy Ltd’s performance has notably outpaced its sector peers and the broader market. Today, the stock outperformed its NBFC sector by 5.17%, while the Sensex index declined by 0.49%, falling 371.40 points to close at 81,849.08 after a flat opening. This divergence emphasises the stock’s relative strength amid a broadly negative market environment.

Over the past year, Prism Medico & Pharmacy Ltd has delivered a remarkable 73.96% return, significantly outperforming the Sensex’s 9.70% gain during the same period. This substantial outperformance highlights the company’s ability to generate value in a challenging market backdrop.

Valuation and Market Capitalisation Context

Despite the recent price surge, Prism Medico & Pharmacy Ltd holds a Mojo Score of 46.0 with a Mojo Grade of Sell, downgraded from Hold as of 17 Nov 2025. The company’s market cap grade stands at 4, indicating a relatively modest market capitalisation within its sector. These metrics provide a nuanced view of the stock’s valuation and risk profile amid its price appreciation.

The stock’s 52-week low remains at Rs.11.62, illustrating the significant recovery and upward trajectory it has experienced over the past year. This wide price range further emphasises the strength of the current rally and the stock’s ability to rebound from lower levels.

Sector and Market Technical Overview

The broader Sensex index is currently trading below its 50-day moving average, although the 50-day average remains above the 200-day moving average, suggesting a mixed technical picture for the market. In contrast, Prism Medico & Pharmacy Ltd’s price action is decisively bullish, trading above all major moving averages, which is a positive technical indicator for the stock’s trend.

This divergence between the stock’s performance and the broader market highlights its relative strength within the NBFC sector and the wider market environment.

Summary of Key Metrics

To summarise, Prism Medico & Pharmacy Ltd’s key performance indicators as of 27 Feb 2026 are:

• New 52-week high price: Rs.28.79
• Day’s gain: 5.00%
• Consecutive gain period: 9 days
• Return over 9 days: 69.85%
• 1-year return: 73.96%
• Sensex 1-year return: 9.70%
• Mojo Score: 46.0 (Sell grade)
• Market Cap Grade: 4

The stock’s consistent upward movement and ability to outperform both its sector and the broader market underscore its notable price strength and momentum in recent months.

Conclusion

Prism Medico & Pharmacy Ltd’s attainment of a new 52-week high at Rs.28.79 marks a significant milestone in its price journey, reflecting strong momentum and sustained gains over an extended period. The stock’s performance stands out in the NBFC sector and against the broader market, supported by favourable technical indicators and a substantial return profile over the past year. While valuation metrics and grading suggest a cautious stance, the stock’s price action remains robust and noteworthy within the current market context.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →